Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Guillem Pascual‐Pasto
Sign up to set email alerts
89
Publications
1,036
Citation Statements Received
2,691
Citation Statements Given
How they've been cited
1,222
63
970
3
How they cite others
2,963
187
2,487
17
Affiliations
Hospital Sant Joan de Déu Barcelona
,
Institut de Recerca Sant Joan de Déu
Publications
Order By: Most citations
A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression
Liu
1
,
Ottaviani
2
,
Sefta
3
et al.
2021
Nat Commun
Abstract
Show
118
20
159
2
Get access via publisher
Add to collection
Cite
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity
Heitzeneder
1
,
Bosse
2
,
Zhu
3
et al.
2022
Cancer Cell
192
7
146
0
Get access via publisher
Add to collection
Cite
Glucosylated nanomicelles target glucose-avid pediatric patient-derived sarcomas
Bukchin
1
,
Pascual‐Pasto
2
,
Cuadrado‐Vilanova
3
et al.
2018
Journal of Controlled Release
30
1
72
0
Get access via publisher
Add to collection
Cite
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
Pascual‐Pasto
1
,
Bazán‐Peregrino
2
,
Olaciregui
3
et al.
2019
Sci. Transl. Med.
Abstract
Show
117
0
70
0
Get access via publisher
Add to collection
Cite
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Ordóñez
1
,
Amaral
2
,
Carcaboso
3
et al.
2015
Oncotarget
Abstract
Show
101
5
65
0
2
Get access via publisher
Add to collection
Cite
Epigenetic state determines inflammatory sensing in neuroblastoma
Wolpaw
1
,
Grossmann
2
,
Dessau
3
et al.
2022
Proc. Natl. Acad. Sci. U.S.A.
Abstract
Show
57
12
50
0
Get access via publisher
Add to collection
Cite
Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma
Bosse
1
,
Giudice
2
,
Lane
3
et al.
2022
Abstract
Show
52
3
46
0
Get access via publisher
Add to collection
Cite
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
Pascual‐Pasto
1
,
Olaciregui
2
,
Vilà-Ubach
3
et al.
2016
Cancer Letters
35
1
36
0
Get access via publisher
Add to collection
Cite
1
2
3
4